Thursday, Jul 10

A New Option for Chronic Lyme Patients

Acute Lyme is an accepted infectious disease. It has familiar symptoms of an infection such as fever, rash or malaise. This condition is accepted by mainstream medicine, and the treatment is fairly well defined. However, when Lyme disease develops into chronic Lyme, both the treatment regimen and even the nature

Studies Investigate Relationship Between New Treatment and Reduction in Dysautonomia Symptoms in MS Patients

Synergy Health has published a new study, the first in a series, investigating the relationship between treatment for CCSVI (and its successor treatment, TVAM therapy) and the improvement of the symptoms of dysautonomia among M.S. Patients and other groups suffering from autonomic dysfunction. Read our latest study here: While

A Promising New Treatment for Dysautonomia Patients

Most patients diagnosed with isolated or “pure” dysautonomia – autonomic dysfunction with no underlying neurological condition – generally first seek medical treatment for cardiovascular issues, such as POTS (where the heart rate fluctuates based on body position) or syncope (the tendency to pass out frequently). As a result, dysautonomia is

The Current Status of CCSVI Treatment

Since the condition known as chronic cerebrospinal venous insufficiency (CCSVI) was first described by Dr. Paolo Zamboni in 2008, the relationship between this condition and MS has been investigated and rigorously debated. Yet while Zamboni’s original study saw an over 90% correlation between MS and CCSVI, later studies have cast

Solving the CCSVI Puzzle

CCSVI, as described by Zamboni, is a disturbance of the central nervous system (CNS) venous drainage. The impaired venous drainage seen with CCSVI was postulated to have an effect on multiple sclerosis. Based on the theory of CCSVI, treatment of jugular venous insufficiency has been studied as a potential therapeutic


CCSVI is one of the most controversial topics in modern medical history. CCSVI is held in particular disdain within the neurologic community. University of Buffalo researchers issued a press release regarding their study of CCSVI on March 15th, which was followed shortly by the annual meeting of the American Academy

Carnival of MS Blogs #135

This week, the carnival features these following showstoppers: Lucky Girl from A Little of Everything With a Grain of Salt from Needle Fatigue YouTube Therapy: Making MS Manageable with the World Wide Web from Katie Brind’Amour of Don’t miss all the action! Read more: Carnival of MS Bloggers #135

Ways to Maximize Your Time in the Gym

Joining a gym is easy, but how do you stick to a workout plan as well as make it worth your time? As Brett Hoebel says, “Fitness is not about being than someone else…It’s about being better than you used to be.” Find out how to be a better you

Using Deep Brain Stimulation to Fight Disease Inside the Brain

Experts expect that the 90,000 patients currently treated for Parkinson’s per year will rise 25% annually. Treating this 95,000 people involves the standard Deep Brain Stimulation (DBS), which means electrically stimulating the central or peripheral nervous system, but the cost of this procedures is hefty and the side-effects can be

Chris Wright Battles MS, Joins Mavericks

Have you hear the amazing news about Chris Wright? He just signed with the Dallas Mavericks for a 10 day deal and is the first person to acknowledge playing with MS in the NBA. While playing in Turkey last year, he suffered an MS flare. The doctor there told him